Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
374M
-
Number of holders
-
146
-
Total 13F shares, excl. options
-
282M
-
Shares change
-
+4.05M
-
Total reported value, excl. options
-
$304M
-
Value change
-
+$2.26M
-
Put/Call ratio
-
6.1
-
Number of buys
-
61
-
Number of sells
-
-57
-
Price
-
$1.08
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) as of Q1 2025
165 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share as of Q1 2025.
STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) has 146 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 282M shares
of 374M outstanding shares and own 75.22% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (76.1M shares), VIKING GLOBAL INVESTORS LP (58.7M shares), BlackRock, Inc. (24.6M shares), VANGUARD GROUP INC (17.2M shares), MORGAN STANLEY (10.7M shares), GEODE CAPITAL MANAGEMENT, LLC (7.21M shares), Long Focus Capital Management, LLC (6.7M shares), Tikvah Management LLC (6.55M shares), STATE STREET CORP (6.36M shares), and Sumitomo Mitsui Trust Group, Inc. (6.23M shares).
This table shows the top 146 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.